Rest of Combined Cardiac after Arrhythmia Panel

New York
Approved


Genes

ACTC1, ACTN2, ALMS1, ALPK3, ANKRD1, BAG3, BRAF, CHRM2, CRYAB, CSRP3, DMD, DOLK, DTNA, EMD, EYA4, FHL1, FKRP, FKTN, GAA, GATAD1, GLA, HFE, HRAS, ILK, JPH2, KRAS, LAMA4, LAMP2, LRRC10, MAP2K1, MAP2K2, MIB1, MTND1, MTND5, MTND6, MTTD, MTTG, MTTH, MTTI, MTTK, MTTL1, MTTL2, MTTM, MTTQ, MTTS1, MTTS2, CAVIN4, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYLK2, MYOZ2, MYPN, NEBL, NEXN, NRAS, PDLIM3, PRDM16, PRKAG2, PTPN11, RAF1, RBM20, RIT1, SGCD, SHOC2, SOS1, TAZ, TBX20, TCAP, TMPO, TNNC1, TNNI3, TNNT2, TOR1AIP1, TPM1, TTR, TXNRD2, VCL

Conditions

  • Dilated Cardiomyopathy (DCM)
  • Hypertrophic Cardiomyopathy (HCM)
  • Left Ventricular Noncompaction (LVNC)
  • Noonan Syndrome
  • Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
  • Sudden Cardiac Arrest

Clinical Utility

  • Molecular confirmation of a clinical diagnosis in symptomatic patients
  • Risk assessment of asymptomatic family members of a proband with cardiomyopathy and/or arrhythmia
  • Differentiation of hereditary cardiomyopathy and/or arrhythmia from acquired (non-genetic) cardiomyopathy and/or arrhythmia
  • Recurrence risk calculation

Lab Method

  • Next-Gen Sequencing
  • ExonArray CGH

Test Code

695RE

CPT Codes*

81439x1

ABN Required

No

Turnaround Time**

4 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.